Remdesivir for Treatment of COVID-19 Requiring Oxygen Support: A Cross-Study Comparison From 2 Large, Open-Label Studies.
Saved in:
| Title: | Remdesivir for Treatment of COVID-19 Requiring Oxygen Support: A Cross-Study Comparison From 2 Large, Open-Label Studies. |
|---|---|
| Authors: | Fusco D; Department of Medicine, Tulane Medical Center, New Orleans, Louisiana, USA., Malenica I; Real World Evidence, Gilead Sciences, Inc., Foster City, California, USA.; Department of Biostatistics, University of California, Berkeley, Berkeley, California, USA., Günthard HF; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Gupta SK; Division of Infectious Diseases, Indiana University School of Medicine, Indianapolis, Indiana, USA., Kurbegov D; Sarah Cannon, Nashville, Tennessee, USA., Balani B; Hackensack School of Medicine, Hackensack University Medical Center, Hackensack, New Jersey, USA., Olender S; Department of Internal Medicine, Columbia University in the City of New York, New York, New York, USA., Aberg JA; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Telep LE; Real World Evidence, Gilead Sciences, Inc., Foster City, California, USA., Tian Y; Clinical Bioinformatics and Exploratory Analytics, Gilead Sciences, Inc., Foster City, California, USA., Blair C; Biostatistics, Gilead Sciences, Inc., Foster City, California, USA., Wu G; Biostatistics, Gilead Sciences, Inc., Foster City, California, USA., Haubrich RH; Global Medical Affairs, Gilead Sciences, Inc., Foster City, California, USA., Wang CY; Global Medical Affairs, Gilead Sciences, Inc., Foster City, California, USA., Chokkalingam AP; Real World Evidence, Gilead Sciences, Inc., Foster City, California, USA.; Division of Epidemiology, School of Public Health, University of California, Berkeley, California, USA., Osinusi AO; Clinical Development, Gilead Sciences, Inc., Foster City, California, USA., Wendtner CM; Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilians-University, Munich, Germany., Gottlieb RL; Center for Advanced Heart and Lung Disease, Baylor University Medical Center, Dallas, Texas, USA.; Department of Internal Medicine, Texas A&M Health Science Center, Dallas, Texas, USA.; Department of Internal Medicine, Burnett School of Medicine at TCU, Fort Worth, Texas, USA.; Baylor Scott & White Research Institute, Dallas, Texas, USA. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Nov 22; Vol. 79 (5), pp. 1182-1189. |
| Publication Type: | Journal Article; Comparative Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38920297 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Remdesivir for Treatment of COVID-19 Requiring Oxygen Support: A Cross-Study Comparison From 2 Large, Open-Label Studies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fusco+D%22">Fusco D</searchLink>; Department of Medicine, Tulane Medical Center, New Orleans, Louisiana, USA.<br /><searchLink fieldCode="AU" term="%22Malenica+I%22">Malenica I</searchLink>; Real World Evidence, Gilead Sciences, Inc., Foster City, California, USA.; Department of Biostatistics, University of California, Berkeley, Berkeley, California, USA.<br /><searchLink fieldCode="AU" term="%22Günthard+HF%22">Günthard HF</searchLink>; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gupta+SK%22">Gupta SK</searchLink>; Division of Infectious Diseases, Indiana University School of Medicine, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Kurbegov+D%22">Kurbegov D</searchLink>; Sarah Cannon, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Balani+B%22">Balani B</searchLink>; Hackensack School of Medicine, Hackensack University Medical Center, Hackensack, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Olender+S%22">Olender S</searchLink>; Department of Internal Medicine, Columbia University in the City of New York, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Aberg+JA%22">Aberg JA</searchLink>; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Telep+LE%22">Telep LE</searchLink>; Real World Evidence, Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Tian+Y%22">Tian Y</searchLink>; Clinical Bioinformatics and Exploratory Analytics, Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Blair+C%22">Blair C</searchLink>; Biostatistics, Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Wu+G%22">Wu G</searchLink>; Biostatistics, Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Haubrich+RH%22">Haubrich RH</searchLink>; Global Medical Affairs, Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Wang+CY%22">Wang CY</searchLink>; Global Medical Affairs, Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Chokkalingam+AP%22">Chokkalingam AP</searchLink>; Real World Evidence, Gilead Sciences, Inc., Foster City, California, USA.; Division of Epidemiology, School of Public Health, University of California, Berkeley, California, USA.<br /><searchLink fieldCode="AU" term="%22Osinusi+AO%22">Osinusi AO</searchLink>; Clinical Development, Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Wendtner+CM%22">Wendtner CM</searchLink>; Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilians-University, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Gottlieb+RL%22">Gottlieb RL</searchLink>; Center for Advanced Heart and Lung Disease, Baylor University Medical Center, Dallas, Texas, USA.; Department of Internal Medicine, Texas A&M Health Science Center, Dallas, Texas, USA.; Department of Internal Medicine, Burnett School of Medicine at TCU, Fort Worth, Texas, USA.; Baylor Scott & White Research Institute, Dallas, Texas, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2024 Nov 22; Vol. 79 (5), pp. 1182-1189. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Comparative Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38920297 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/cid/ciae336 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1182 Titles: – TitleFull: Remdesivir for Treatment of COVID-19 Requiring Oxygen Support: A Cross-Study Comparison From 2 Large, Open-Label Studies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fusco D – PersonEntity: Name: NameFull: Malenica I – PersonEntity: Name: NameFull: Günthard HF – PersonEntity: Name: NameFull: Gupta SK – PersonEntity: Name: NameFull: Kurbegov D – PersonEntity: Name: NameFull: Balani B – PersonEntity: Name: NameFull: Olender S – PersonEntity: Name: NameFull: Aberg JA – PersonEntity: Name: NameFull: Telep LE – PersonEntity: Name: NameFull: Tian Y – PersonEntity: Name: NameFull: Blair C – PersonEntity: Name: NameFull: Wu G – PersonEntity: Name: NameFull: Haubrich RH – PersonEntity: Name: NameFull: Wang CY – PersonEntity: Name: NameFull: Chokkalingam AP – PersonEntity: Name: NameFull: Osinusi AO – PersonEntity: Name: NameFull: Wendtner CM – PersonEntity: Name: NameFull: Gottlieb RL IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 11 Text: 2024 Nov 22 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1537-6591 Numbering: – Type: volume Value: 79 – Type: issue Value: 5 Titles: – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Type: main |
| ResultId | 1 |